Calls
1
u/Smooth_Ninja_1191
Reddit r/ValueInvesting
Win Rate
0.0%
return
-0.6%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jul 31
$46.80
-0.6%
Novo has fallen sharply while obesity demand remains structurally underpenetrated; the market is focused on competition and near-term setbacks. If current bad news is mostly priced in, successful pipeline execution can restore growth and drive the stock toward the author’s 100 target. Long NVO at current levels as a contrarian value play on Novo’s long-term growth optionality in obesity and cardiometabolic disease. Intensifying competition, clinical or regulatory pipeline failures, and continued negative sentiment could invalidate the thesis.
Novo has fallen sharply while obesity demand remains structurally underpenetrated; the market is focused on competition and near-term setbacks. If current bad news is mostly priced in, successful pipeline execution can restore growth and drive the stock toward the author’s 100 target. Long NVO at current levels as a contrarian value play on Novo’s long-term growth optionality in obesity and cardiometabolic disease. Intensifying competition, clinical or regulatory pipeline failures, and continued negative sentiment could invalidate the thesis.
GLP-1 / Obesity
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Smooth_Ninja_1191 has 1 trade ideas tracked on Buzzberg across 1 tickers since July 2026. Most covered: NVO.
